Multicenter midterm follow-up results using the gore septal occluder for atrial septal defect closure in pediatric patients

2016 ◽  
Vol 89 (7) ◽  
pp. E226-E232 ◽  
Author(s):  
Jochen Grohmann ◽  
Christian Wildberg ◽  
Peter Zartner ◽  
Tariq Abu-Tair ◽  
Gleb Tarusinov ◽  
...  
Keyword(s):  
Atrial Septal Defect ◽  
Pediatric Patients ◽  
Septal Defect ◽  
Defect Closure ◽  
Atrial Septal Defect Closure

NEW-ONSET AND PERSISTENT MIGRAINE EARLY AFTER PERCUTANEOUS ATRIAL SEPTAL DEFECT CLOSURE DISAPPEAR AT FOLLOW-UP

2008 ◽  
Vol 63 (4) ◽  
pp. 262-268 ◽  
Author(s):  
A. Voet ◽  
J.G.L.M. Luermans ◽  
V. Thijs ◽  
L. Herroelen ◽  
M. C. Post ◽  
...  
Keyword(s):  
Atrial Septal Defect ◽  
Septal Defect ◽  
Defect Closure ◽  
Atrial Septal Defect Closure ◽  
New Onset

scholarly journals Totally robotic atrial septal defect closure: 7-year single-institution experience and follow-up

2014 ◽  
Vol 19 (6) ◽  
pp. 933-937 ◽  
Author(s):  
Cangsong Xiao ◽  
Changqing Gao ◽  
Ming Yang ◽  
Gang Wang ◽  
Yang Wu ◽  
...  
Keyword(s):  
Atrial Septal Defect ◽  
Septal Defect ◽  
Defect Closure ◽  
Single Institution ◽  
Atrial Septal Defect Closure

Transcatheter Atrial Septal Defect Closure Assisted by Intracardiac Echocardiography: 3-Year Follow-Up

2004 ◽  
Vol 17 (2) ◽  
pp. 95-98 ◽  
Author(s):  
MARIO ZANCHETTA ◽  
GIANLUCA RIGATELLI ◽  
LUIGI PEDON ◽  
MARCO ZENNARO ◽  
ANTONIO CARROZZA ◽  
...  
Keyword(s):  
Atrial Septal Defect ◽  
Septal Defect ◽  
Intracardiac Echocardiography ◽  
Defect Closure ◽  
Atrial Septal Defect Closure

Atrial septal defect closure with the new Cardia Ultrasept II™ device with interposed Goretex patch: Mexican experience – has the perforation of Ivalon’s membrane been solved?

2018 ◽  
Vol 28 (5) ◽  
pp. 709-714 ◽  
Author(s):  
Roberto Mijangos-Vázquez ◽  
Antonio J. García-Montes ◽  
Elena M. Soto-López ◽  
Verónica Guarner-Lans ◽  
Carlos Zabal
Keyword(s):  
Right Ventricular ◽  
Atrial Septal Defect ◽  
Septal Defect ◽  
Good Alternative ◽  
Minimum Length ◽  
Defect Closure ◽  
Atrial Septal Defect Closure ◽  
End Point ◽  
Goretex Patch

AbstractObjectivesThe objective of this study was to demonstrate the safety and feasibility of using the new Cardia Ultrasept II™ device with interposed Goretex patch referring to the perforation of polyvinyl alcohol membrane.BackgroundGreat advances have been made in the development of devices for closure of atrial septal defect. The Cardia Ultrasept II™ with interposed Goretex patch is the modified last generation of Cardia devices, having the advantage of a super-low profile within the atria and an integral locking delivery-retrieval mechanism that ensures safe deployment. In addition, with the interposition of the Goretex, it has been possible to abolish perforation of Ivalon’s membrane as a complication.Methods and resultsPatients with ostium secundum atrial septal defect with surrounding rims with a minimum length of 5 mm and who underwent atrial septal defect closure with the new Ultrasept II™ with Goretex patch were included from two paediatric cardiac centres. Primary end point was to determine perforation of the Goretex membrane at follow-up; secondary end point included right ventricular diastolic diameter. In total, 30 patients underwent atrial septal defect closure at a median age of 6 (1–29) years. At follow-up for 6 (range, 1–15) months, freedom from perforations was 100%. A continuous decrease in right ventricular diastolic diameter was found with an initial median of 30 (25–49) mm and after catheterisation of 27.5 (18–33) mm, p=0.01, and Z-score of 2.6 (1.7–3.6) versus 1.9 (1–2.9) after procedure, p=0.01.ConclusionsThe new modified generation of the Ultrasept II™ device with interposed Goretex patch is a good alternative to achieve atrial septal defect closure safely and feasibly with no membrane perforation at follow-up.

Sign in / Sign up

Export Citation Format

Share Document